Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial

BACKGROUND: Acute respiratory distress syndrome (ARDS) results in vascular leakage, inflammation and respiratory failure. There are currently no approved pharmacological treatments for ARDS and standard of care involves treatment of the underlying cause, and supportive care. The vascular leakage may...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellingan, Geoff, Brealey, David, Mancebo, Jordi, Mercat, Alain, Patroniti, Nicolò, Pettilä, Ville, Quintel, Michael, Vincent, Jean-Louis, Maksimow, Mikael, Jalkanen, Markku, Piippo, Ilse, Ranieri, V. Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683224/
https://www.ncbi.nlm.nih.gov/pubmed/29132404
http://dx.doi.org/10.1186/s13063-017-2234-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683224/
https://www.ncbi.nlm.nih.gov/pubmed/29132404
http://dx.doi.org/10.1186/s13063-017-2234-7

Ejemplares similares